Table of Contents

1 Study Coverage

• 1.1 Parecoxib Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Parecoxib Market Size Growth Rate by Product
  • 1.4.2 Intravenous Injection
  • 1.4.3 Muscle Injection
• 1.5 Market by End User
  • 1.5.1 Global Parecoxib Market Size Growth Rate by End User
  • 1.5.2 Hospital
  • 1.5.3 Clinic
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Parecoxib Market Size
  • 2.1.1 Global Parecoxib Revenue 2014-2025
  • 2.1.2 Global Parecoxib Sales 2014-2025
• 2.2 Parecoxib Growth Rate by Regions
  • 2.2.1 Global Parecoxib Sales by Regions
  • 2.2.2 Global Parecoxib Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Parecoxib Sales by Manufacturers
  • 3.1.1 Parecoxib Sales by Manufacturers
  • 3.1.2 Parecoxib Sales Market Share by Manufacturers
  • 3.1.3 Global Parecoxib Market Concentration Ratio (CR5 and HHI)
• 3.2 Parecoxib Revenue by Manufacturers
  • 3.2.1 Parecoxib Revenue by Manufacturers (2014-2019)
  • 3.2.2 Parecoxib Revenue Share by Manufacturers (2014-2019)
• 3.3 Parecoxib Price by Manufacturers
• 3.4 Parecoxib Manufacturing Base Distribution, Product Types
  • 3.4.1 Parecoxib Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Parecoxib Product Type
  • 3.4.3 Date of International Manufacturers Enter into Parecoxib Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Parecoxib Sales by Product
• 4.2 Global Parecoxib Revenue by Product
• 4.3 Parecoxib Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Parecoxib Breakdown Data by End User

6 North America

• 6.1 North America Parecoxib by Countries
  • 6.1.1 North America Parecoxib Sales by Countries
  • 6.1.2 North America Parecoxib Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Parecoxib by Product
• 6.3 North America Parecoxib by End User

7 Europe

• 7.1 Europe Parecoxib by Countries
  • 7.1.1 Europe Parecoxib Sales by Countries
  • 7.1.2 Europe Parecoxib Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Parecoxib by Product
• 7.3 Europe Parecoxib by End User

8 Asia Pacific

• 8.1 Asia Pacific Parecoxib by Countries
  • 8.1.1 Asia Pacific Parecoxib Sales by Countries
  • 8.1.2 Asia Pacific Parecoxib Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Parecoxib by Product
• 8.3 Asia Pacific Parecoxib by End User

9 Central & South America

• 9.1 Central & South America Parecoxib by Countries
  • 9.1.1 Central & South America Parecoxib Sales by Countries
  • 9.1.2 Central & South America Parecoxib Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Parecoxib by Product
• 9.3 Central & South America Parecoxib by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Parecoxib by Countries
  • 10.1.1 Middle East and Africa Parecoxib Sales by Countries
  • 10.1.2 Middle East and Africa Parecoxib Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Parecoxib by Product
• 10.3 Middle East and Africa Parecoxib by End User

11 Company Profiles

• 11.1 Pfizer
  • 11.1.1 Pfizer Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Pfizer Parecoxib Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Pfizer Parecoxib Products Offered
  • 11.1.5 Pfizer Recent Development
• 11.2 Kelun Group
  • 11.2.1 Kelun Group Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Kelun Group Parecoxib Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Kelun Group Parecoxib Products Offered
  • 11.2.5 Kelun Group Recent Development

12 Future Forecast

• 12.1 Parecoxib Market Forecast by Regions
  • 12.1.1 Global Parecoxib Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Parecoxib Revenue Forecast by Regions 2019-2025
• 12.2 Parecoxib Market Forecast by Product
  • 12.2.1 Global Parecoxib Sales Forecast by Product 2019-2025
  • 12.2.2 Global Parecoxib Revenue Forecast by Product 2019-2025
• 12.3 Parecoxib Market Forecast by End User
• 12.4 North America Parecoxib Forecast
• 12.5 Europe Parecoxib Forecast
• 12.6 Asia Pacific Parecoxib Forecast
• 12.7 Central & South America Parecoxib Forecast
• 12.8 Middle East and Africa Parecoxib Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Parecoxib Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

The global Parecoxib market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Parecoxib market based on company, product type, end user and key regions.

This report studies the global market size of Parecoxib in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Parecoxib in these regions.
This research report categorizes the global Parecoxib market by top players/brands, region, type and end user. This report also studies the global Parecoxib market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer
Kelun Group

Market size by Product
Intravenous Injection
Muscle Injection
Market size by End User
Hospital
Clinic

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Parecoxib market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Parecoxib market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Parecoxib companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Parecoxib submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Parecoxib are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Parecoxib market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.